Cargando…
PRIMA-1 inhibits Y220C p53 amyloid aggregation and synergizes with cisplatin in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide. Although many therapeutic options are available, several factors, including the presence of p53 mutations, impact tumor development and therapeutic resistance. TP53 is the second most frequently mutated gen...
Autores principales: | Paz, Mariana M., Ferretti, Giulia D. S., Martins-Dinis, Mafalda M. C., Ferreira, Beatriz I. S., Faier-Pereira, Amanda, Barnoud, Thibaut, Moreira, Otacilio C., Silva, Jerson L., Cordeiro, Yraima, Rangel, Luciana P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123287/ https://www.ncbi.nlm.nih.gov/pubmed/37101558 http://dx.doi.org/10.3389/fmolb.2023.1165132 |
Ejemplares similares
-
Expanding the prion concept to cancer biology: dominant-negative effect of aggregates of mutant p53 tumour suppressor
por: Silva, Jerson L., et al.
Publicado: (2013) -
Mutant p53 Aggregates into Prion-like Amyloid Oligomers and Fibrils: IMPLICATIONS FOR CANCER
por: Ano Bom, Ana P. D., et al.
Publicado: (2012) -
Come prima meglio di prima : commedia in tre atti /
por: Pirandello, Luigi, 1867-1936
Publicado: (1929) -
Mammalian prion protein (PrP) forms conformationally different amyloid intracellular aggregates in bacteria
por: Macedo, Bruno, et al.
Publicado: (2015) -
RNA modulates aggregation of the recombinant mammalian prion protein by direct interaction
por: Kovachev, Petar Stefanov, et al.
Publicado: (2019)